3x ETFs and zero-day options: Is the asset management industry becoming more predatory?
"We have seen the creation of financial products that dig into the worst part of human psychology." ...
SEMTECH INVESTIGATION: Semtech Corp. (SMTC) Investigated For Securities Fraud; Investors Should Contact Block & Leviton To Potentially Recover Losses
BOSTON, MA / ACCESS Newswire / February 12, 2025 / Block & Leviton is investigating Semtech Corporation (Nasdaq:SMTC) for potential ...
Bank of America Securities Remains a Buy on Edwards Lifesciences (EW)
Bank of America Securities analyst Travis Steed maintained a Buy rating on Edwards Lifesciences (EW – Research Report) today. The company’s ...
EuropaWire21h
Novartis Acquires Anthos Therapeutics to Advance Abelacimab in Stroke and Thrombosis Prevention
Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...
Biogen's soft guidance and a decline in sales at MS portfolio weigh
Cambridge, Mass.-based Biogen had per-share earnings of $1.83 for the quarter, up from $1.71 a year ago. Adjusted for one-time items, EPS came to $3.44, ahead of the $3.35 FactSet consensus.